SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:d9a86348-7d6b-4d7d-a8fb-259deabce681"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:d9a86348-7d6b-4d7d-a8fb-259deabce681" > Consumption of ultr...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007218naa a2200757 4500
001oai:lup.lub.lu.se:d9a86348-7d6b-4d7d-a8fb-259deabce681
003SwePub
008231218s2023 | |||||||||||000 ||eng|
0247 a https://lup.lub.lu.se/record/d9a86348-7d6b-4d7d-a8fb-259deabce6812 URI
0247 a https://doi.org/10.1016/j.lanepe.2023.1007712 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
1001 a Cordova, Reynaldau International Agency for Research on Cancer, World Health Organization,University of Vienna4 aut
2451 0a Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases : a multinational cohort study
264 1c 2023
520 a Background: It is currently unknown whether ultra-processed foods (UPFs) consumption is associated with a higher incidence of multimorbidity. We examined the relationship of total and subgroup consumption of UPFs with the risk of multimorbidity defined as the co-occurrence of at least two chronic diseases in an individual among first cancer at any site, cardiovascular disease, and type 2 diabetes. Methods: This was a prospective cohort study including 266,666 participants (60% women) free of cancer, cardiovascular disease, and type 2 diabetes at recruitment from seven European countries in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Foods and drinks consumed over the previous 12 months were assessed at baseline by food-frequency questionnaires and classified according to their degree of processing using Nova classification. We used multistate modelling based on Cox regression to estimate cause-specific hazard ratios (HR) and their 95% confidence intervals (CI) for associations of total and subgroups of UPFs with the risk of multimorbidity of cancer and cardiometabolic diseases. Findings: After a median of 11.2 years of follow-up, 4461 participants (39% women) developed multimorbidity of cancer and cardiometabolic diseases. Higher UPF consumption (per 1 standard deviation increment, ∼260 g/day without alcoholic drinks) was associated with an increased risk of multimorbidity of cancer and cardiometabolic diseases (HR: 1.09, 95% CI: 1.05, 1.12). Among UPF subgroups, associations were most notable for animal-based products (HR: 1.09, 95% CI: 1.05, 1.12), and artificially and sugar-sweetened beverages (HR: 1.09, 95% CI: 1.06, 1.12). Other subgroups such as ultra-processed breads and cereals (HR: 0.97, 95% CI: 0.94, 1.00) or plant-based alternatives (HR: 0.97, 95% CI: 0.91, 1.02) were not associated with risk. Interpretation: Our findings suggest that higher consumption of UPFs increases the risk of cancer and cardiometabolic multimorbidity. Funding: Austrian Academy of Sciences, Fondation de France, Cancer Research UK, World Cancer Research Fund International, and the Institut National du Cancer.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653 a Cancer
653 a Cardiovascular diseases
653 a Diabetes
653 a Diet
653 a Multimorbidity
653 a Ultra-processed foods
7001 a Viallon, Vivianu International Agency for Research on Cancer, World Health Organization4 aut
7001 a Fontvieille, Emmau International Agency for Research on Cancer, World Health Organization4 aut
7001 a Peruchet-Noray, Laiau International Agency for Research on Cancer, World Health Organization4 aut
7001 a Jansana, Annau International Agency for Research on Cancer, World Health Organization4 aut
7001 a Wagner, Karl Heinzu University of Vienna4 aut
7001 a Kyrø, Cecilie4 aut
7001 a Tjønneland, Anneu University of Copenhagen4 aut
7001 a Katzke, Verenau German Cancer Research Centre4 aut
7001 a Bajracharya, Rashmitau German Cancer Research Centre4 aut
7001 a Schulze, Matthias B.u University of Potsdam,German Institute of Human Nutrition4 aut
7001 a Masala, Giovannau Institute for Cancer Research, Prevention and Clinical Network (ISPRO)4 aut
7001 a Sieri, Sabinau Istituto Nazionale dei Tumori4 aut
7001 a Panico, Salvatoreu University of Naples Federico II4 aut
7001 a Ricceri, Fulviou University of Turin4 aut
7001 a Tumino, Rosariou Hyblean Association for Epidemiological Research4 aut
7001 a Boer, Jolanda M.A.u National Institute for Public Health and the Environment (RIVM)4 aut
7001 a Verschuren, W. M.Moniqueu University Medical Center Utrecht,National Institute for Public Health and the Environment (RIVM)4 aut
7001 a van der Schouw, Yvonne T.u University Medical Center Utrecht4 aut
7001 a Jakszyn, Paulau Ramon Llull University,Catalan Institute of Oncology4 aut
7001 a Redondo-Sánchez, Danielu Andalusian School Of Public Health (EASP),CIBER Epidemiology and Public Health (CIBERESP)4 aut
7001 a Amiano, Pilaru CIBER Epidemiology and Public Health (CIBERESP)4 aut
7001 a Huerta, José Maríau CIBER Epidemiology and Public Health (CIBERESP),Murcia Regional Health Council4 aut
7001 a Guevara, Marcelau Health Research Institute of Navarra (IDISNA),CIBER Epidemiology and Public Health (CIBERESP)4 aut
7001 a Borné, Yanu Lund University,Lunds universitet,Nutritionsepidemiologi,Forskargrupper vid Lunds universitet,Nutrition Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)med-boy
7001 a Sonestedt, Emilyu Lund University,Lunds universitet,Nutritionsepidemiologi,Forskargrupper vid Lunds universitet,Nutrition Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)medf-eso
7001 a Tsilidis, Konstantinos K.u University of Ioannina,Imperial College London4 aut
7001 a Millett, Christopheru NOVA University Lisbon,Imperial College London4 aut
7001 a Heath, Alicia K.u Imperial College London4 aut
7001 a Aglago, Elom K.u Imperial College London4 aut
7001 a Aune, Dagfinnu Imperial College London,Cancer Registry of Norway, Institute of Population-Based Cancer Research4 aut
7001 a Gunter, Marc J.u Imperial College London,International Agency for Research on Cancer, World Health Organization4 aut
7001 a Ferrari, Pietrou International Agency for Research on Cancer, World Health Organization4 aut
7001 a Huybrechts, Ingeu International Agency for Research on Cancer, World Health Organization4 aut
7001 a Freisling, Heinzu International Agency for Research on Cancer, World Health Organization4 aut
7102 a International Agency for Research on Cancer, World Health Organizationb University of Vienna4 org
7730 t The Lancet Regional Health - Europeg 35q 35x 2666-7762
8564 u http://dx.doi.org/10.1016/j.lanepe.2023.100771x freey FULLTEXT
8564 8u https://lup.lub.lu.se/record/d9a86348-7d6b-4d7d-a8fb-259deabce681
8564 8u https://doi.org/10.1016/j.lanepe.2023.100771

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy